In 2016, Birendra and DiNardo reported the cases of three patients with R/R IDH1-mutated AML treated with ivosidenib, showing fever, chills, dyspnea, and pleuro-pericardial effusions [118]. Here, IDH1 is linked to acute myeloid leukemia.